Procella Therapeutics AB Revenue and Competitors
Estimated Revenue & Valuation
- Procella Therapeutics AB's estimated annual revenue is currently $7.9M per year.
- Procella Therapeutics AB's estimated revenue per employee is $155,000
Employee Data
- Procella Therapeutics AB has 51 Employees.
- Procella Therapeutics AB grew their employee count by 82% last year.
Procella Therapeutics AB's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Quality, VP | Reveal Email/Phone |
2 | Manufacturing Manager | Reveal Email/Phone |
3 | Scientist | Reveal Email/Phone |
4 | Research associate | Reveal Email/Phone |
5 | Scientist in Analytical Development | Reveal Email/Phone |
6 | Scientist | Reveal Email/Phone |
7 | Analytical Scientist | Reveal Email/Phone |
8 | Research assosiate | Reveal Email/Phone |
9 | Research Associate | Reveal Email/Phone |
10 | Research Associate | Reveal Email/Phone |
Procella Therapeutics AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Procella Therapeutics AB?
Procella Therapeutics was founded on the vision to make new, cell-based therapies for patients who are running out of options. In particular, Procella is focusing on stem cell treatments for patients with advanced heart failure. Procella's technology is based on years of work at Harvard University and Karolinska Institute and has been shown in animals that unique and novel heart progenitor cells have the capability of creating new muscle in hearts damaged from a heart attack. To further develop this technology, Procella has signed a collaboration agreement with AstraZeneca and is driving towards first in human studies.
keywords:N/AN/A
Total Funding
51
Number of Employees
$7.9M
Revenue (est)
82%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.6M | 122 | -9% | N/A |